Stock listing

OTC:NVOS Novo Integrated Sciences, Inc. Stock

Follow Novo Integrated Sciences, Inc. into a list and get an email when it puts out news.

Share price · OTC:NVOS

$0.0022 USD +0.0013 (+144.4%)

Close on Nov 20, 2026

Past year -56.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.0008 – $0.0022 USDNov 20, 2026
Volume
330 sharesNov 20, 2026
Market cap
$43,407 USDAt the close on Nov 20, 2026 · price × 19.73M shares outstanding
52-week range
$0.0001 – $0.0310 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$3 USDMedian day 110 shares · 22 days with no trades · last 3 months, Sep 3, 2026 – Nov 20, 2026
Novo Integrated Sciences, Inc. logo

Daily closes

Last 3 months, Sep 3, 2026 – Nov 20, 2026 · OTC:NVOS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.0022+0.0013+144.4%$0.0008$0.0022$0.0008330
$0.00090.00000.0%$0.0009$0.0009$0.00090
$0.0009+0.0003+50.0%$0.0009$0.0009$0.0009100
$0.0006-0.0002-25.0%$0.0006$0.0006$0.00061,330
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.0008+0.0002+33.3%$0.0006$0.0008$0.00062,613
$0.0006-0.0002-25.0%$0.0006$0.0006$0.00062,669
$0.0008+0.0002+33.3%$0.0008$0.0008$0.00082,800
$0.00060.00000.0%$0.0006$0.0006$0.000612,571
$0.00060.00000.0%$0.0006$0.0006$0.00061,050
$0.00060.00000.0%$0.0006$0.0006$0.00063,411
$0.00060.00000.0%$0.0006$0.0006$0.00061,001
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.0006-0.0001-14.3%$0.0006$0.0006$0.00064,651
$0.0007+0.0001+16.7%$0.0007$0.0007$0.0007919
$0.00060.00000.0%$0.0039$0.0039$0.00062,555
$0.0006-0.0014-70.0%$0.0006$0.0006$0.0006100
$0.00200.00000.0%$0.0020$0.0020$0.00200
$0.00200.00000.0%$0.0020$0.0020$0.00200
$0.00200.00000.0%$0.0020$0.0020$0.00200
$0.00200.00000.0%$0.0020$0.0020$0.00208,000
$0.00200.00000.0%$0.0020$0.0020$0.00200
$0.0020+0.0002+11.1%$0.0018$0.0020$0.00184,934
$0.0018+0.0004+28.6%$0.0018$0.0018$0.0018110
$0.00140.00000.0%$0.0014$0.0014$0.00140
$0.00140.00000.0%$0.0014$0.0014$0.00140
$0.0014-0.0002-12.5%$0.0014$0.0014$0.0014110
$0.00160.00000.0%$0.0016$0.0016$0.00160
$0.0016+0.0010+166.7%$0.0016$0.0016$0.00165,036
$0.00060.00000.0%$0.0006$0.0006$0.0006259
$0.0006-0.0033-84.6%$0.0014$0.0014$0.00061,780
$0.00390.00000.0%$0.0039$0.0039$0.00391,000
$0.00390.00000.0%$0.0006$0.0039$0.00061,104
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.00395,645
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.0039500
$0.00390.00000.0%$0.0039$0.0040$0.00391,895
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0039$0.0039$0.00390
$0.00390.00000.0%$0.0009$0.0039$0.00092,372
$0.0039+0.0004+11.4%$0.0040$0.0040$0.003910,022

Splits

3 splits since 2015 · OTC:NVOS · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
1-for-10Consolidation
1-for-20Consolidation
Ticker
OTC:NVOS
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
OTC
Currency
USD

Latest news

All Novo Integrated Sciences, Inc. news

Novo Integrated Sciences, Inc. on 6ix

Sector
Health care
Industry
Health care services
News releases
34 in all · newest Feb 22, 2021 · oldest 2014
Decks
1 deck · latest Sep 30, 2021

Valuation

price Nov 20, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
1.26

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Novo Integrated Sciences, Inc. · OTC:NVOSUS$43,407n/an/an/an/an/an/an/a1.26
Adherium Ltd. · ASX:ADRUS$1.74MUS$3.78Mn/a7.0×n/an/an/an/an/a
Accendra Health, Inc. · NYSE:ACHUS$1.57MUS$9.96Mn/a0.0×0.1×n/a−6.7%n/a0.51
CardioComm Solutions, Inc. · TSXV:EKGUS$1.38MUS$1.62Mn/a8.5×n/an/a−194.6%n/a0.00
Mobile-health Network Solutions · NASDAQ:MNDRUS$842,830−US$1.00Mn/a−0.1×n/a0.1×−41.2%0.0×0.38
Aesthetic Medical International Holdings Group Ltd. · OTC:PAIYYUS$584,251US$33.65Mn/a0.3×3.6×n/a−7.4%n/a0.43
ARCpoint Inc · TSXV:ARCUS$463,091US$1.90Mn/a3.1×n/an/a−349.3%n/a0.00
Com-Guard.com, Inc. · OTC:CGUDUS$428,603US$6.21Mn/a1,552×n/an/an/an/a0.31
FOXO Technologies Inc. · OTC:FOXOUS$252,365US$209,687n/a0.0×n/a2.9×−12.3%0.0×1.30
CYIOS Corp. · OTC:CYIOUS$182,065US$2.21Mn/an/an/an/an/an/a-0.14
Cardiff Lexington Corporation · OTC:CDIXUS$110,236US$24.55Mn/a2.7×n/an/a−126.4%n/a0.74
Median of the othersUS$523,671US$2.99M2.7×1.8×1.5×−41.2%0.0×0.38

Team and board

Officers

OfficerRole
Robert MattacchioneBoard Chairman & CEO
Chris DavidChief Operating Officer
Vivek SethiNVOS Principal Financial Officer (PFO)

Board

DirectorRole
Alex FlesiasChairman, Nominating & Corporate Governance Committee
Robert MattacchioneBoard Chairman & CEO
Sarfaraz AliChairman, Compensation Committee, Audit Committee, Board of Directors

Events

QuarterResultsShare move
Q1 2025Dec 18, 2024+1.6%
Q3 2024Jul 19, 2024 · After close−2.6%
Q2 2024Apr 15, 2024 · After close+32.8%
Q1 2024Jan 22, 2024 · After close−4.5%
Q3 2023Jul 17, 2023 · After close−7.2%
Q2 2023May 26, 2023 · After close−9.9%
Q3 2022Jul 14, 2022 · After close−1.9%
Q2 2022Apr 13, 2022 · After close+4.1%
Q1 2022Dec 14, 2021−1.5%
Q3 2021Jul 14, 2021+2.6%
All 11 quarters
QuarterResultsShare move
Q2 2021Apr 14, 2021−10.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2021)Investor deck25 slidesSep 30, 2021

Open Decks

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017FY2016
Revenue13.3M12.6M11.7M9.31M7.86M9.42M8.89M7.96M7.18M7.47M
Cost of revenue7.55M7.62M6.94M5.48M4.80M5.90M5.47M4.99M4.67M4.76M
Gross profit5.74M4.95M4.80M3.82M3.06M3.52M3.42M2.98M2.51M2.71M
Research and development000
Selling, general and administrative14.0M13.5M14.4M8.09M7.29M4.02M4.88M3.03M2.39M2.93M
Operating income-8.31M-8.55M-25.0M-4.27M-4.26M-785.6K-1.57M-164.9K122.0K-401.6K
Depreciation and amortization2.26M2.30M3.02M1.72M1.45M97.1K73.4K67.8K72.6K1.01K
EBITDA-6.05M-6.25M-22.0M-2.55M-2.82M-688.5K-1.50M-97.1K194.5K-400.6K
Interest expense652.4K5.12M1.59M165.0K156.7K222.2K564.5K554.7K0523.3K
Income before tax-16.1M-13.3M-33.1M-4.47M-4.92M-403.6K-2.12M-164.9K-346.2K-2.77M
Income tax-22.3K22.3K178.1K-46.4K282.6K7.52K111.7K02.40M
Net income-16.1M-13.2M-33.0M-4.46M-4.92M-392.0K-2.11M-164.9K-340.5K-2.77M
Earnings per share, basic-0.89-1.30-1.13-1.80-2.13-0.18-1.02-0.09-13.29

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017FY2016
Cash and equivalents844.6K416.3K12.7M8.29M2.07M2.08M675.7K1.90M110.3K14.1K
Short-term investments000
Receivables3.15M1.47M6.38M2.28M2.04M1.76M1.73M1.50M2.31M1.19M
Inventory1.00M1.11M645.1K339.4K157.4K-785.8K1
Current assets5.41M4.39M20.1M11.1M4.29M4.10M2.57M3.65M2.57M14.1K
Property, plant and equipment8.61M3.16M3.41M400.3K303.0K318.7K318.7K
Goodwill6.55M7.58M11.4M9.49M636.9K623.1K604.1K399.4K0
Total assets32.1M35.6M71.8M62.0M35.4M32.3M4.74M5.51M2.89M27.9K
Accounts payable3.24M3.51M1.62M1.45M883.8K1.14M1.31M1.70M4.94M13.1K
Current liabilities14.6M7.90M12.7M8.46M2.60M3.03M3.35M4.27M9.97M13.1K
Long-term debt65.0K1.11M6.12M952.1K1.20M1.22M5.53M11.6K11.6K
Total debt4.71M4.47M19.8M13.7M4.39M5.13M1.61M5.54M6.33M
Total liabilities17.5M11.1M27.4M18.2M5.82M6.73M4.57M9.80M9.97M13.1K
Shareholders' equity14.9M24.8M44.4M43.9M29.6M25.6M201.4K-4.27M-7.08M14.8K
Shares outstanding18.0M10.2M29.1M2.48M2.30M2.17M2.08M1.78M208.5K

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017FY2016
Cash from operations-2.24M-2.24M-5.88M-1.02M-441.7K-822.3K-934.5K-810.7K101.4K-175.6K
Capital spending-49.2K-49.2K-190.2K-255.9K-12.1K-107.6K-178.6K-38.2K-55.0K-113.9K
Free cash flow-2.29M-2.29M-6.07M-1.28M-453.8K-929.9K-1.11M-848.9K46.4K-289.5K
Cash from investing-49.2K-49.2K3.00M657.1K-842.9K-217.2K-749.5K-462.3K-113.9K
Cash from financing763.9K763.9K-427.1K4.32M-271.7K3.07M-11.6K3.11M402.2K187.9K
Dividends paid000
Share buybacks0-62.5K150.0K150.0K
Change in cash-1.76M-1.76M-6.11M6.23M-15.9K1.41M-1.22M1.79M42.2K12.3K

Open Financials

Cap table

Built by 6ix from Novo Integrated Sciences, Inc.’s releases

Common shares
19,730,247
Fully diluted
19,730,247

Fully diluted

LineShares
Common shares19,730,247

Share count over time

CountShares
Nov 22, 202619,730,247

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Michael Pope
Other companies: Focus Universal Inc. (Chairman of the Board · Since at least Sep 12, 2019); Boxlight Corporation (Chairman of the Board · Since at least Aug 6, 2019)
Director · Feb 19, 2021 – Feb 23, 2022 · Past
Alex FlesiasDirector · Feb 19, 2021 – Feb 19, 2021 · Past
Alex FlesiasChairman, Nominating & Corporate Governance Committee · Since at least Nov 4, 2026
Chris DavidChief Operating Officer · Since at least Nov 4, 2026
Michael Joseph GaynorDirector · Feb 19, 2021 – Feb 19, 2021 · Past
Pierre Joseph DalcourtDirector · Feb 19, 2021 – Feb 19, 2021 · Past
Robert Letterio OlivaDirector · Feb 19, 2021 – Apr 19, 2022 · Past
Robert MattacchioneBoard Chairman & CEO · Since at least Feb 19, 2021
Sarfaraz AliChairman, Compensation Committee, Audit Committee, Board of Directors · Since at least Nov 5, 2026
Sterling M JimenezPrincipal Financial Officer · Apr 20, 2021 – Apr 20, 2021 · Past
All 12 people
PersonSeat
Thomas Edward BrayPrincipal Financial Officer · Feb 19, 2021 – Feb 19, 2021 · Past
Vivek SethiNVOS Principal Financial Officer (PFO) · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Novo Integrated Sciences, Inc.